Ctnnb1 mutation detection kit, method, and use in hcc detection and management
AssigneeJBS Science Inc.
InventorsWei Song, Surbhi Jain, Jamin Dean Steffen
Life of this patent
Estimating the term…
Loading patent…
AssigneeJBS Science Inc.
InventorsWei Song, Surbhi Jain, Jamin Dean Steffen
Estimating the term…
Provided herein are a kit and method for detecting mutations in CTNNB1, and their use in detection and management of hepatocellular carcinoma (HCC). The kit comprises a first pair of primers, configured to specifically bind sequences flanking the genomic region for amplifying the genomic region in a first PCR reaction; and at least one clamp, each configured to bind to one first allele but not any second allele at an annealing temperature in the first PCR reaction to thereby selectively suppress amplification of the one first allele but still allow amplification of other second allele(s). A method for detecting or monitoring recurrence of HCC is further disclosed, which comprises determining levels of five DNA markers, including CTNNB1 mutations, hTERT mutations, TP53 mutations, RASSF1A methylation, and GSTP1 methylation.
A kit for characterizing, in a biological sample containing at least one first allele of CTNNB1, at least one second allele in a genomic region of CTNNB1, the kit comprising:
A method of detecting or monitoring a recurrence of hepatocellular carcinoma (HCC), in a DNA sample obtained from a biological sample of a subject in need thereof, comprising the step of:
Dependencies are inferred from the claim text.